Characteristics of the reparative effect of mesenchymal stem cells during modulation of cannabinoid CB2-receptors in a model of peripheral neuropathy
Abstract
Objective. To study morphological changes in the distal segment of the sciatic nerve upon modulation of cannabinoid CB2-receptors of mesenchymal stem cells in peripheral neuropathy model.
Materials and methods. Peripheral neuropathy was modeled by excision of a section of the sciatic nerve in Wistar rats. On the 7th day of the experiment, mesenchymal stem cells derived from the rat's adipose tissue were injected into the site of nerve injury at a dose of 1106 cells/kg with no additional impacts, with preliminary incubation with the CB2-receptors agonist AM1241 or the selective antagonist AM630. On the 21st and 90th days of the experiment, a histological assessment of the distal segment of the sciatic nerve was performed.
Results. It was found that activation of CB2-receptors by the selective agonist AM1241 in the soft tissues of the area of sciatic nerve injury, as well as on mesenchymal stem cell's membranes, was accompanied by a decrease in the number of damaged nerve fibers and proliferation of Schwann cells in the distal segment of sciatic nerve by the 90th day of the experiment. Inhibition of CB2-receptors by a selective AM630 antagonist was characterized by suppression of the reparative effect of mesenchymal stem cells.
Conclusion. The data obtained indicate the role of cannabinoid CB2-receptors in the implementation of the regenerative effects of mesenchymal stem cells.
About the Authors
A.-M. V. YerofeyevaRussian Federation
S. N. Rjabceva
Russian Federation
A. Y. Molchanova
Институт физиологии НАН Беларуси
Russian Federation
Russian Federation
References
1. Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev. Neurol. Paris. 2019; 175 (1-2): 16 -25.
2. Cavalli E., Mammana S., Nicoletti F. et al. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol. 2019; 33: 2058738419838383.
3. Zhou Y., Yamamoto Y., Xiao Z. etal. The Immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. J. Clin. Med. 2019; 8 (7): 1025.
4. Erofeeva A.-M. V., Molchanova A. Y. Impact of adiposederived allogeneic mesenchymal stem cell transplantation on nociceptive reactions and gait parameters in rats with experimental peripheral neuropathy. Vestsi Natsyyanal'nay akademii navuk Belarusi. Seryya medytsynskikh navuk. 2022: 19 (4): 404 12. (in Russian)
5. Guo W., Chu Y. X., Imai S. et al. Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models. Mol Pain. 2016; 12: 1744806916658043.
6. Siniscalco D., Giordano C., Galderisi U. et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front. Integr. Neurosci. 2011; 5 (79): 1-10.
7. Xie J., Xiao D., Xu Y. et al. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pretreatment involving cannabinoid receptor CB2. Oncotarget. 2016; 7 (6): 6436 47.
8. Lin X., Xu Z., Carey L. et l. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. Pain. 2022; 163 (5): 834 -51.
9. Choi S., Choi H. J., Cheong Y. et al. Intemal-specific morphological analysis of sciatic nerve fibers in a radiofrequency-induced animal neuropathic pain model. PLoS One. 2013; 8 (9): e73913.
Review
For citations:
Yerofeyeva A.V., Rjabceva S.N., Molchanova A.Y. Characteristics of the reparative effect of mesenchymal stem cells during modulation of cannabinoid CB2-receptors in a model of peripheral neuropathy. Healthcare. 2023;(12):75-80. (In Russ.)
Views:
6
Email this article 